The information on this page is for informational purposes only and does not constitute medical advice. Consult your genetic counselor or specialist physician for treatment decisions.

Myeloproliferative Neoplasm (JAK2-related)

Prevalence: ~300K

oncologic

Official·OMIM:263300

Polycythemia vera and essential thrombocythemia caused by JAK2 V617F mutation.

Associated Genes

No gene records found associated with this disease.